DETECTING ADALIMUMAB SERUM LEVEL AND ANTI-DRUG ANTIBODIES - FUTURE TOOL IN MONITORING SPONDYLOARTHRITIS PATIENTS?

被引：1
|
作者：
Deaconu, C. [1 ]
Opris, D. [1 ,2 ]
Mazilu, D. [1 ,2 ]
Borangiu, A. [1 ,2 ]
Groseanu, L. [1 ,2 ]
Negru, M. [1 ,2 ]
Constantinescu, C. [1 ,2 ]
Saulescu, I. [1 ,2 ]
Bojinca, V. [1 ,2 ]
Vlad, V. [1 ]
Balanescu, A. [1 ,2 ]
Predeteanu, D. [1 ,2 ]
Ionescu, R. [1 ,2 ]
机构：
[1] SfantaMaria Clin Hosp, Dept Rheumatol & Internal Med, Bucharest, Romania
[2] Univ Med & Pharm Carol Davila, Bucharest, Romania
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-209124.178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10.06
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [31] Anti-drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as-needed infliximab treatment
    Patil, Abhishek
    Upadhyaya, Sundeep
    Dawar, Reetika
    Dadhaniya, Nikunjkumar
    Sood, Isha
    Gupta, Sirinder J.
    Handa, Rohini
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (09) : 1638 - 1643
  • [32] EVALUATING THE COST-EFFECTIVENESS OF PERSONALIZED TREATMENT WITH ADALIMUMAB USING SERUM DRUG LEVEL AND ANTI-ADALIMUMAB ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS
    Krieckaert, C.
    Nair, S. C.
    Nurmohamed, M. T.
    van Dongen, C. J.
    Lems, W. F.
    Lafeber, F. P.
    Bijlsma, J. W.
    Wolbink, G.
    Welsing, P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 104 - 104
  • [33] Anti-drug Antibodies Formation During Tapering and Stopping of Methotrexate in Rheumatoid Arthritis Patients with Longstanding Use of Adalimumab
    Layegh, Zohra
    de Jong, Pascal
    Atiqi, Sadaf
    Loeff, Floris
    Dijk, Lisanne
    Vaz, Gaelle
    Dolhain, Radboud J. E. M.
    Rispens, Theo
    Wolbink, Gertjan
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2121 - 2122
  • [34] Functional cellular based assay reveals neutralising anti-drug antibodies in IBD patients treated with maintenance adalimumab
    Casteele, N. Vande
    Peeters, M.
    Ferrante, M.
    Compernolle, G.
    Van Assche, G.
    Vermeire, S.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S268 - S269
  • [35] Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial
    Marona, Jose
    Rodrigues-Manica, Santiago
    Gomes, Joao Lagoas
    Lopes, Carina
    Iria, Ines
    Bernardes, Miguel
    Santos, Helena
    Tavares-Costa, Jose
    Madruga-Dias, Joao
    Pinto, Patricia
    Bernardo, Alexandra
    Maia, Sara
    Branco, Jaime
    Goncalves, Joao
    Pimentel-Santos, Fernando
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [36] Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients
    Bloem, Karien
    van Leeuwen, Astrid
    Verbeek, Gerrit
    Nurmohamed, Michael T.
    Wolbink, Gerrit Jan
    van der Kleij, Desiree
    Rispens, Theo
    JOURNAL OF IMMUNOLOGICAL METHODS, 2015, 418 : 29 - 38
  • [37] BASIC CONCEPTS: ANALYSIS OF ANTI-DRUG ANTIBODIES AND SERUM CONCENTRATIONS OF BIOLOGICALS
    Pascual-Salcedo, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 35 - 35
  • [38] Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
    Nakase, H.
    Motoya, S.
    Matsumoto, T.
    Watanabe, K.
    Hisamatsu, T.
    Yoshimura, N.
    Ishida, T.
    Kato, S.
    Nakagawa, T.
    Esaki, M.
    Nagahori, M.
    Matsui, T.
    Naito, Y.
    Kanai, T.
    Suzuki, Y.
    Nojima, M.
    Watanabe, M.
    Hibi, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) : 873 - 882
  • [39] Homogenous Mobility Shift Assay (HMSA) Overcomes the Limitations of ELISA and ECLIA Assays for Monitoring Infliximab (IFX), Adalimumab (ADA), and Associated Anti-drug Antibodies in Serum
    Egea-Pujol, Laia
    Reddy, Rukmini
    Patel, Shruti
    Christie, Raymond
    Salbato, Jared
    Shah, Shawn
    Hauenstein, Scott
    Singh, Sharat
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S548 - S548
  • [40] CLINICAL IMPORTANCE OF ANTI-DRUG AND SERUM DRUG LEVEL TESTING IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
    Drynda, S.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 499 - 500
12345